How is age-related macular degeneration diagnosed? Which patient is at risk of the disease? What are the treatment options? These, in short, are the questions to which some of the most authoritative have been asked to answerspecialists in ophthalmology, during the webinar recently held within the training course of Floretina 2021, on the topic ‘Neovascular Amd in real life’, chaired by Edoardo Midena, professor of Diseases of the visual apparatus and director of the School of Specialization in Ophthalmology of the University of Padua, and by Stanislao Rizzo, director of the Ophthalmology complex operating unit of the A. Gemelli Irccs University Hospital of Rome, organized with the unconditional contribution of Bayer.
Read Also
- Gamma wipes Barbara de Regil’s smile: she and Sherlyn were trapped by the storm that hits Quintana Roo Oct 3, 2020
- Laetitia Casta, top physicist after 4 children and without retouching: this is how she does it Jul 16, 2021
- The government launches the housing component of the National Refoundation Council Nov 24, 2022
- “People don’t like the woman involved in the government”: Rodolfo Hernández is ambiguous in a radio interview and criticism rains down on him May 27, 2022
- Guns are now the leading cause of death for children in the US May 27, 2022
- Al Bano Carrisi irrepressible with Orietta Berti. Pinched in the car like that Jul 30, 2021
- 30 people from educational facilities report symptoms of poisoning in Puchuncaví Nov 22, 2022